Pfizer is planning to sell Lipitor at generic prices directly to patients, part of an effort to hold onto sales of cholesterol fighter after the drug loses patent protection.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer to Sell Lipitor Directly to Patients After Patent Expires
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account